UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery

Annals of oncology, 2012-10, Vol.23 (10), p.2731-2737

2012

Volltextzugriff (PDF)

Validation of the Korean Version of the EORTC QLQ-C30

Quality of life research, 2004-05, Vol.13 (4), p.863-868

2004

Volltextzugriff (PDF)

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2013-11, Vol.82 (2), p.276-281

2013

Volltextzugriff (PDF)

EP-1082: Involved-site radiotherapy based on FDG-PET/CT after R-CHOP chemotherapy in diffuse large B cell lymphoma

Radiotherapy and oncology, 2014, Vol.111, p.S14-S14

2014

Volltextzugriff (PDF)

Acquired resistance mechanisms to INC280, a MET inhibitor in MET-amplified lung cancer cells

European journal of cancer (1990), 2016-12, Vol.69, p.S135-S136

2016

Volltextzugriff (PDF)

Implication of Tumor Location on Lymph Node Metastasis in Carcinoma of Maxillary Sinus: Indication for Elective Nodal Treatment

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E376-E376

2016

Volltextzugriff (PDF)

EP-1070: Outcome of radiotherapy in intracranial germinoma at basal ganglia/thalamus

Radiotherapy and oncology, 2014, Vol.111, p.S9-S10

2014

Volltextzugriff (PDF)

Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma

Annals of oncology, 2008-02, Vol.19 (2), p.242-246

2008

Volltextzugriff (PDF)

153 Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in Anaplastic Lymphoma Kinase-Rearranged Lung Cancer

European journal of cancer (1990), 2012-11, Vol.48, p.47-47

2012

Volltextzugriff (PDF)

EP-1040 REDUCED-DOSE RADIOTHERAPY BY THE CHEMORESPONSIVENESS FOR THE PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

Radiotherapy and oncology, 2012-05, Vol.103, p.S407-S407

2012

Volltextzugriff (PDF)

EP-1052 RADICAL CHEMORADIOTHERAPY AS A TREATMENT OF CHOICE FOR THE ELDERLY WITH LOCALLY ADVANCED NSCLC

Radiotherapy and oncology, 2012-05, Vol.103, p.S411-S411

2012

Volltextzugriff (PDF)

AOS10 Prognostic factors for patients with leptomeningeal metastases from solid tumours

European journal of cancer (1990), 2012-04, Vol.48, p.S6-S7

2012

Volltextzugriff (PDF)

Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial

Annals of oncology, 2017-02, Vol.28 (2), p.292-297

2017

Volltextzugriff (PDF)

Antibiotic use during the last days of life in cancer patients

European journal of cancer care, 2006-03, Vol.15 (1), p.74-79

2006

Volltextzugriff (PDF)

Mechanisms of resistance to mobocertinib in EGFR exon 20 insertion-mutant non-small cell lung cancer (NSCLC)

European journal of cancer (1990), 2022-10, Vol.174, p.S110-S111

2022

Volltextzugriff (PDF)

Treatment strategies based on the molecular subtypes of transformed small cell lung cancer (t-SCLC)

European journal of cancer (1990), 2022-10, Vol.174, p.S120-S120

2022

Volltextzugriff (PDF)

Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study

Annals of oncology, 2013-08, Vol.24 (8), p.2080-2087

2013

Volltextzugriff (PDF)

Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer

Annals of oncology, 2007-12, Vol.18 (12), p.2009-2014

2007

Volltextzugriff (PDF)

EP-1149 Albumin-to-alkaline phosphatase ratio in nasopharyngeal cancer: a propensity score matching analysis

Radiotherapy and oncology, 2019-04, Vol.133, p.S637-S637

2019

Volltextzugriff (PDF)

EP-1165 Failure Patterns of Cervical Lymph Nodes in Metastases of Unknown Primary according to Target Volume

Radiotherapy and oncology, 2019-04, Vol.133, p.S645-S645

2019

Volltextzugriff (PDF)

Generalization and representativeness of phase III immune checkpoint inhibitor trials in NSCLC

Annals of oncology, 2017-09, Vol.28, p.v472-v473

2017

Volltextzugriff (PDF)

EP-1166 Optimal timing for salvage surgery after definitive radiotherapy in hypopharyngeal cancer

Radiotherapy and oncology, 2019-04, Vol.133, p.S645-S646

2019

Volltextzugriff (PDF)

Phase II study of osimertinib in NSCLC patients with EGFR exon 20 insertion mutation: A multicenter trial of the Korean Cancer Study Group (LU17-19)

Annals of oncology, 2019-10, Vol.30, p.v628

2019

Volltextzugriff (PDF)

1529P - Phase II study of osimertinib in NSCLC patients with EGFR exon 20 insertion mutation: A multicenter trial of the Korean Cancer Study Group (LU17-19)

Annals of oncology, 2019-10, Vol.30, p.v628-v628

2019

Volltextzugriff (PDF)

8727 Outcome after high-dose methotrexate and radiotherapy for primary central nervous system lymphoma

European journal of cancer supplements, 2009, Vol.7 (2), p.501-501

2009

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(81)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Life Sciences & Biomedicine
(35)
Humans
(31)
Female
(25)
Biological And Medical Sciences
(24)
Male
(24)
Medical Sciences
(22)
Middle Aged
(22)
Oncology
(21)
Adult
(17)
Aged
(17)
Hematology, Oncology And Palliative Medicine
(16)
Antineoplastic Agents
(14)
Pharmacology. Drug Treatments
(14)
Treatment Outcome
(14)
Retrospective Studies
(10)
Fundamental And Applied Biological Sciences. Psychology
(9)
Survival Analysis
(9)
Disease-Free Survival
(8)
Fundamental Immunology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery

Validation of the Korean Version of the EORTC QLQ-C30

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

EP-1082: Involved-site radiotherapy based on FDG-PET/CT after R-CHOP chemotherapy in diffuse large B cell lymphoma

Acquired resistance mechanisms to INC280, a MET inhibitor in MET-amplified lung cancer cells

Implication of Tumor Location on Lymph Node Metastasis in Carcinoma of Maxillary Sinus: Indication for Elective Nodal Treatment

EP-1070: Outcome of radiotherapy in intracranial germinoma at basal ganglia/thalamus

Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma

153 Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in Anaplastic Lymphoma Kinase-Rearranged Lung Cancer

EP-1040 REDUCED-DOSE RADIOTHERAPY BY THE CHEMORESPONSIVENESS FOR THE PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EP-1052 RADICAL CHEMORADIOTHERAPY AS A TREATMENT OF CHOICE FOR THE ELDERLY WITH LOCALLY ADVANCED NSCLC

AOS10 Prognostic factors for patients with leptomeningeal metastases from solid tumours

Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial

Antibiotic use during the last days of life in cancer patients

Mechanisms of resistance to mobocertinib in EGFR exon 20 insertion-mutant non-small cell lung cancer (NSCLC)

Treatment strategies based on the molecular subtypes of transformed small cell lung cancer (t-SCLC)

Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study

Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer

EP-1149 Albumin-to-alkaline phosphatase ratio in nasopharyngeal cancer: a propensity score matching analysis

EP-1165 Failure Patterns of Cervical Lymph Nodes in Metastases of Unknown Primary according to Target Volume

Generalization and representativeness of phase III immune checkpoint inhibitor trials in NSCLC

EP-1166 Optimal timing for salvage surgery after definitive radiotherapy in hypopharyngeal cancer

Phase II study of osimertinib in NSCLC patients with EGFR exon 20 insertion mutation: A multicenter trial of the Korean Cancer Study Group (LU17-19)

1529P - Phase II study of osimertinib in NSCLC patients with EGFR exon 20 insertion mutation: A multicenter trial of the Korean Cancer Study Group (LU17-19)

8727 Outcome after high-dose methotrexate and radiotherapy for primary central nervous system lymphoma

Suchergebnisse filtern